Midlife income, occupation, APOE status, and dementia: A population-based study

Neurology

Volumn 59, Issue 6, 2002, Pages 887-893

  Anttila, T ^a   Helkala, E L ^a   Kivipelto, M ^a   Hallikainen, M ^b   Alhainen, K ^c   Heinonen, H ^a   Mannermaa, A ^b   Tuomilehto, J ^d,e   Soininen, H ^a,b   Nissinen, A ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c Joensuu Central Hospital   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

AGE; AGED; ARTICLE; CONTROLLED STUDY; DEMENTIA; FEMALE; FOLLOW UP; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; OCCUPATION; POPULATION RESEARCH; PRIMARY HEALTH CARE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SOCIOECONOMICS;

EID: 0037167553     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.59.6.887     Document Type: Article

References (33)

1. Evans DA, Hebert LE, Beckett LA, et al. Education and other measures of socioeconomic status and risk of incident Alzheimer disease in defined population of older persons. Arch Neurol 1997;54:1399-1405.
2. Bonaiuto S, Rocca WA, Lippi A, et al. Education and occupation as risk factors for dementia: a population-based case-control study. Neuroepidemiology 1995;14:101-109.
3. Dartigues JF, Gagnon M, Letenneur L, et al. Principal lifetime occupation and cognitive impairment in a French elderly cohort (Paquid). Am J Epidemiol 1992;135:981-988.
4. Stern Y, Gurland B, Tatemichi TK, Tang MX, Wilder D, Mayeux R. Influence of education and occupation on the incidence of Alzheimer's disease. JAMA 1994;271:1004-1010.
5. Beard CM, Kokmen E, Offord KP, Kurland LT. Lack of association between Alzheimer's disease and education, occupation, marital status, or living arrangement. Neurology 1992; 42:2063-2068.
6. Zhang MY, Katzman R, Salmon D, et al. The prevalence of dementia and Alzheimer's disease in Shanghai, China: impact of age, gender, and education. Ann Neurol 1990;27:428-437.
7. Launer LJ, Andersen K, Dewey ME, et al. Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups European Studies of Dementia. Neurology 1999;52:78-84.
8. Ott A, Breteler MM, van Harskamp F, et al. Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam Study. BMJ 1995;310:970-973.
9. Letenneur L, Gilleron V, Commenges D, Helmer C, Orgogozo JM, Dartigues JF. Are sex and educational level independent predictors of dementia and Alzheimer's disease? Incidence data from the PAQUID project. J Neurol Neurosurg Psychiatry 1999;66:177-183.
10. Ott A, van Rossum CT, van Harskamp F, van de Mheen H, Hofman A, Breteler MM. Education and the incidence of dementia in a large population-based study: the Rotterdam Study. Neurology 1999;52:663-666.
11. Cobb JL, Wolf PA, Au R, White R, D'Agostino RB. The effect of education on the incidence of dementia and Alzheimer's disease in the Framingham Study. Neurology 1995;45:1707-1712.
12. Myers RH, Schaefer EJ, Wilson PW, et al. Apolipoprotein E epsilon 4 association with dementia in a population-based study: The Framingham Study. Neurology 1996;46:673-677.
13. Tilvis RS, Strandberg TE, Juva K. Apolipoprotein E. phenotypes, dementia and mortality in a prospective population sample. J Am Geriatr Soc 1998;46:712-715.
14. Evans DA, Beckett LA, Field TS, et al. Apolipoprotein E epsilon 4 and incidence of Alzheimer's disease in a community population of older persons. JAMA 1997;277:822-824.
15. Nalbantoglu J, Gilfix BM, Bertrand P, et al. Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies. Ann Neurol 1994;36:889-895.
16. Geschwind D, Karrim J, Nelson SF, Miller B. The apolipoprotein E epsilon 4 allele is not a significant risk factor for frontotemporal dementia. Ann Neurol 1998;44:134-138.
17. Puska P, Tuomilehto J, Salonen J, et al. Changes in coronary risk factors during comprehensive five-year community programme to control cardiovascular diseases (the North Karelia Project). BMJ 1979;2:1173-1178.
18. Puska P, Salonen J, Nissinen. A, et al. Change in risk factors for coronary heart disease during 10 years of a community intervention programme (North Karelia Project). BMJ 1983; 287:1840-1844.
19. Vartiainen E, Puska P, Jousilahti P, Korhonen HJ, Tuomilehto J, Nissinen A. Twenty-year trends in coronary risk factors in North Karelia and in other areas of Finland. Int J Epidemiol 1994;23:495-504.
20. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
21. McKhann G, Drachman D, Folstein M, Katzlan R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
22. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology 1993;43: 250-260.
23. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990;31:545-548.
24. Tsukamoto K, Watanabe T, Matsushima T, et al. Determination by PCR-RFLP of apo E genotype in a Japanese population. J Lab Clin Med 1993;121:598-602.
25. Helisalmi S, Valve R, Karvonen MK, et al. The leucine (7)-toproline (7) polymorphism in the signal peptide of neuropeptide Y is not associated with Alzheimer's disease or the link apolipoprotein E. Neurosci Lett 2000;287:25-28.
26. Helmer C, Letenneur L, Rouch I, et al. Occupation during life and risk of dementia in French elderly community residents. J Neurol Neurosurg Psychiatry 2001;71:303-309.
27. Hebert R, Lindsay J, Verreault R, Rockwood K, Hill G, Dubois MF. Vascular dementia: incidence and risk factors in the Canadian Study of Health and Aging. Stroke 2000;31:1487-1493.
28. Canadian Study of Health and Aging Working Group. The Canadian Study of Health and Aging: risk factors for Alzheimer's disease in Canada. Neurology 1994;44:2073-2080.
29. Tuomilehto J, Geboers J, Salonen J, Nissinen A, Kuulasmaa K, Puska P. Decline in cardiovascular mortality in North Karelia and other parts of Finland. BMJ 1986;35:1068-1071.
30. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, et al. for the WHO MONICA Project. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 2000;355: 675-687.
31. Bretsky PM, Buckwalter JG, Seeman TE, et al. Evidence for an interaction between apolipoprotein E genotype, gender, and Alzheimer disease. Alzheimer Dis Assoc Disord 1999;13: 216-221.
32. Launer LJ, Wind AW, Deeg DJ. Nonresponse pattern and bias in a community-based cross-sectional study of cognitive functioning among the elderly. Am J Epidemiol 1994; 139:803-812.
33. Fratiglioni L, Jorm AF, Grut M, et al. Predicting dementia from the Mini-Mental State Examination in an elderly population: the role of education. J Clin Epidemiol 1993;46:281-287.